Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis.
Smith
E B
EB
University of Texas Medical Branch, Galveston.
Wiss
K
K
Hanifin
J M
JM
Jordon
R E
RE
Rapini
R P
RP
Lasser
A E
AE
Kirschenbaum
M B
MB
Millikan
L E
LE
Parish
L C
LC
Rapaport
M J
MJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000499:Allylamine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives; D000588:Amines / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003022:Clotrimazole / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D014008:Tinea Pedis / Q000188:drug therapy*
D000588:Amines; D000935:Antifungal Agents; D007093:Imidazoles; D000499:Allylamine; C029178:naftifine; D003022:Clotrimazole